Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

35.26
+1.083.16%
Pre-market: 35.03-0.2300-0.65%04:20 EDT
Volume:1.25M
Turnover:43.34M
Market Cap:6.47B
PE:-18.40
High:35.45
Open:34.56
Low:33.94
Close:34.18
Loading ...

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results

GlobeNewswire
·
25 Feb

Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey
·
24 Feb

Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares

Insider Monkey
·
21 Feb

Legend Biotech Corp : TD Cowen Cuts Target Price to $62 From $67

THOMSON REUTERS
·
21 Feb

Positive Developments in Carvykti Therapy Propel Legend Biotech to ‘Buy’ Rating

TIPRANKS
·
18 Feb

Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts?

Insider Monkey
·
14 Feb

Arcutis Biotherapeutics (ARQT) Surges 15.9%: Is This an Indication of Further Gains?

Zacks
·
13 Feb

Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts

Insider Monkey
·
08 Feb

Barclays Keeps Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
27 Jan

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?

Zacks
·
24 Jan

Strong Buy Recommendation for Legend Biotech Amidst Robust Sales and Strategic Expansions

TIPRANKS
·
23 Jan

Barclays Sticks to Its Buy Rating for Legend Biotech (LEGN)

TIPRANKS
·
23 Jan

Legend Biotech Corp : Jefferies Cuts Target Price to $91 From $94

THOMSON REUTERS
·
23 Jan

Legend Biotech price target lowered to $84.28 from $92.97 at Goldman Sachs

TIPRANKS
·
23 Jan

Legend Biotech Reports Strong CARVYKTI® Sales for Q4 2024

TIPRANKS
·
22 Jan

Legend Biotech Corp: Carvykti® Generated About $334 Mln in Net Trade Sales During Quarter Ended Dec 31, 2024

THOMSON REUTERS
·
22 Jan